Gary Landreth, Paige Cramer, and other researchers at Case Western Reserve have published results in the journal Science that an already approved drug bexarotene used for treating a type of cutaneous T-cell lymphoma has dramatically reversed memory loss and amyloid buildup in the brains of mice. Maria Carrillo of the Alzheimer’s Association comments.
Leave a Reply